Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hyperpolarized Gas MRI Optimization for Lung Disorders
NCT02748798Phase 1Terminated
- Sponsor
- Thunder Bay Regional Health Research Institute
- Start
- Nov 2020
- Primary completion
- Oct 2021
- Countries
- 1
01
Overview
Phase 1, open-label trial (2 arms), sponsored by Thunder Bay Regional Health Research Institute. Primary endpoint: Signal to Noise Ratio at 2 years. Started Nov 2020; status: terminated.
Beyond the preview
Go deeper on NCT02748798.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02748798.